Medicine
Sacubitril and Valsartan 49 mg/51 mg tablet
Sacubitril and Valsartan 49 mg/51 mg tablet is a generic prescription medicine for oral use, made by 25 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 25°C (77°F), excursions permitted between 15° and 30°C (59° and…
Key facts
- Active ingredient (INN)
- Sacubitril and Valsartan
- Brand
- Sold under the generic name
- Strength
- 49 mg/51 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 blister pack, 180 tablets, 60 tablets and 75 more
- Manufacturers
- Alembic PharmaceuticalsIndiaTorrent PharmaceuticalsIndiaZydus LifesciencesIndiaAscend LaboratoriesIndiaBioconIndiaAurobindo PharmaIndiaCamber PharmaceuticalsIndiaDr. Reddy's LaboratoriesIndiaLaurus LabsIndia25 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 25°C (77°F), excursions permitted between 15° and 30°C (59° and 86°F). Protect from moisture.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C09DX04 Sacubitril and Valsartan
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 16 October 2024
- Identifiers
- RxCUI 1656340, 1656349, 1656354DailyMed set ID 5928f174-83e5-4c74-b15a-138338a70295, a1fa7066-8ab4-47e3-a701-6c5170700d11, 43bcdbc7-a635-bb4e-e063-6294a90a990f +27NDC 62332-557, 70954-976, 73190-018 +28Application ANDA213682, ANDA213676, ANDA213605 +13
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 25 labelers. The register lists 78 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 46708-557-10 | Alembic PharmaceuticalsIndia | 4 November 2024 |
| 180 tablet, film coated in 1 bottle | 46708-557-45 | Alembic PharmaceuticalsIndia | 4 November 2024 |
| 60 tablet, film coated in 1 bottle | 46708-557-60 | Alembic PharmaceuticalsIndia | 4 November 2024 |
| 1000 tablet, film coated in 1 bottle | 46708-557-91 | Alembic PharmaceuticalsIndia | 4 November 2024 |
| 100 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 62332-557-10 | Alembic PharmaceuticalsIndia | 4 November 2024 |
| 180 tablet, film coated in 1 bottle | 62332-557-45 | Alembic PharmaceuticalsIndia | 4 November 2024 |
| 60 tablet, film coated in 1 bottle | 62332-557-60 | Alembic PharmaceuticalsIndia | 4 November 2024 |
| 1000 tablet, film coated in 1 bottle | 62332-557-91 | Alembic PharmaceuticalsIndia | 4 November 2024 |
| 180 tablet, film coated in 1 bottle | 67877-708-51 | Ascend LaboratoriesIndia | 23 July 2025 |
| 60 tablet, film coated in 1 bottle | 67877-708-60 | Ascend LaboratoriesIndia | 23 July 2025 |
| 1 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 67877-949-33 | Ascend LaboratoriesIndia | 23 July 2025 |
| 180 tablet, film coated in 1 bottle | 67877-949-51 | Ascend LaboratoriesIndia | 23 July 2025 |
| 60 tablet, film coated in 1 bottle | 67877-949-60 | Ascend LaboratoriesIndia | 23 July 2025 |
| 500 tablet in 1 bottle | 13668-635-05 | Torrent PharmaceuticalsIndia | 16 July 2025 |
| 180 tablet in 1 bottle | 13668-635-33 | Torrent PharmaceuticalsIndia | 16 July 2025 |
| 60 tablet in 1 bottle | 13668-635-60 | Torrent PharmaceuticalsIndia | 16 July 2025 |
| 100 blister pack in 1 carton / 10 tablet in 1 blister pack | 13668-635-74 | Torrent PharmaceuticalsIndia | 16 July 2025 |
| 500 tablet in 1 bottle | 13668-746-05 | Torrent PharmaceuticalsIndia | 16 July 2025 |
| 180 tablet in 1 bottle | 13668-746-33 | Torrent PharmaceuticalsIndia | 16 July 2025 |
| 60 tablet in 1 bottle | 13668-746-60 | Torrent PharmaceuticalsIndia | 16 July 2025 |
| 100 blister pack in 1 carton / 10 tablet in 1 blister pack | 13668-746-74 | Torrent PharmaceuticalsIndia | 16 July 2025 |
| 10 blister pack in 1 carton / 10 tablet in 1 blister pack | 70710-1273-4 | Zydus LifesciencesIndia | 8 July 2025 |
| 60 tablet in 1 bottle | 70710-1273-6 | Zydus LifesciencesIndia | 8 July 2025 |
| 180 tablet in 1 bottle | 70710-1273-8 | Zydus LifesciencesIndia | 8 July 2025 |
| 10 blister pack in 1 carton / 10 tablet in 1 blister pack | 70771-1922-4 | Zydus LifesciencesIndia | 8 July 2025 |
| 60 tablet in 1 bottle | 70771-1922-6 | Zydus LifesciencesIndia | 8 July 2025 |
| 180 tablet in 1 bottle | 70771-1922-8 | Zydus LifesciencesIndia | 8 July 2025 |
| 180 tablet, film coated in 1 bottle | 84386-082-18 | Aurobindo PharmaIndia | 26 October 2026 |
| 60 tablet, film coated in 1 bottle | 84386-082-60 | Aurobindo PharmaIndia | 26 October 2026 |
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 84386-082-78 | Aurobindo PharmaIndia | 26 October 2026 |
| 30 tablet, film coated in 1 bottle | 70377-032-11 | BioconIndia | 17 July 2025 |
| 60 tablet, film coated in 1 bottle | 70377-032-12 | BioconIndia | 17 July 2025 |
| 180 tablet, film coated in 1 bottle | 70377-032-13 | BioconIndia | 17 July 2025 |
| 500 tablet, film coated in 1 bottle | 70377-032-14 | BioconIndia | 17 July 2025 |
| 180 tablet, film coated in 1 bottle | 31722-674-18 | Camber PharmaceuticalsIndia | 23 July 2025 |
| 60 tablet, film coated in 1 bottle | 31722-674-60 | Camber PharmaceuticalsIndia | 23 July 2025 |
| 180 tablet, film coated in 1 bottle | 43598-644-18 | Dr. Reddy's LaboratoriesIndia | 16 July 2025 |
| 60 tablet, film coated in 1 bottle | 43598-644-60 | Dr. Reddy's LaboratoriesIndia | 16 July 2025 |
| 180 tablet, film coated in 1 bottle | 42385-931-18 | Laurus LabsIndia | 11 November 2024 |
| 30 tablet, film coated in 1 bottle | 42385-931-30 | Laurus LabsIndia | 11 November 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Sacubitril and Valsartan 49 mg/51 mg tablet.
Other strengths and forms of Sacubitril and Valsartan
Clinical summary
Sacubitril and Valsartan is a fixed-dose combination of an angiotensin 2 receptor blocker and a neprilysin inhibitor. It is available as tablets and oral pellets. MedsAcross supplies Sacubitril and Valsartan for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Sacubitril and ValsartanFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- ENTRESTO prescribing information (Novartis Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Entresto: European public assessment report (EPAR) · European Medicines Agency
- Neparvis: European public assessment report (EPAR) · European Medicines Agency
Need Sacubitril and Valsartan 49 mg/51 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.